Background: By using the body’s own protective system to fight cancer, immunotherapy is not only effective but also is associated with fewer side effects than chemotherapy. Objectives: This article provides an overview of four types of immunotherapy (monoclonal antibodies, chimeric antigen...

Neuroendocrine tumors (NETs), including gastroenteropancreatic NETs, or GEP-NETs, are heterogenous tumors that arise from diffuse neuroendocrine cells and other organs, such as the lung, ovary, and thyroid. Lutetium Lu 177 dotatate (Lutathera®) is a newly approved targeted therapy for patients with...

Background: The hepatic arterial infusion (HAI) pump is a treatment-delivery method based on the principle of targeting the tumor site directly and can be used alone or in combination with systemic chemotherapy. Objectives: The intent of this article is to serve as a resource for oncology nurses to...

Background: Inhibitors of BRAF and the downstream signaling protein MEK have improved outcomes for patients with BRAF-mutant advanced malignant melanoma. Despite their ease of administration, these oral therapies pose adherence challenges. Objectives: This article aims to increase awareness of...